Business Description
Vista Pharmaceuticals Ltd
ISIN : INE427C01021
Total Employee Number:
30Compare
Compare
Traded in other countries / regions
524711.India IPO Date
1994-12-16Description
Vista Pharmaceuticals Ltd is an Indian company engaged in a single operating segment, which is the manufacturing of Pharmaceutical products. The company offers over-the-counter and prescription generic drug products such as tablets, capsules, and liquids covering various therapeutic categories. Some of the drugs in tablet dosage forms are Sulfamethoxazole and Trimethoprim, Bismuth Subgallate, Pyrantel Pamoate, Aspirin, Ibuprofen, Ranitidine HCl, and others. Nifedipine, Piroxicam, and Indomethacin are the drugs offered by the company in a capsule dosage form. The company generates all of its operating revenue from sales within its domestic market.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | -0.7 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 0.61 | |||||
Beneish M-Score | -2.12 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 76.3 | |||||
3-Year EBITDA Growth Rate | -54.7 | |||||
3-Year EPS without NRI Growth Rate | -10.7 | |||||
3-Year FCF Growth Rate | -21 | |||||
3-Year Book Growth Rate | -15.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.93 | |||||
9-Day RSI | 43.09 | |||||
14-Day RSI | 42.9 | |||||
3-1 Month Momentum % | -8.15 | |||||
6-1 Month Momentum % | -9.62 | |||||
12-1 Month Momentum % | -30.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.92 | |||||
Quick Ratio | 0.26 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 625.43 | |||||
Days Sales Outstanding | 176.65 | |||||
Days Payable | 414.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.9 | |||||
Shareholder Yield % | -11.6 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 3.29 | |||||
Operating Margin % | -284.57 | |||||
Net Margin % | -223.38 | |||||
EBITDA Margin % | -264.87 | |||||
FCF Margin % | -95.99 | |||||
OCF Margin % | -81.51 | |||||
ROE % | -28.6 | |||||
ROA % | -20.52 | |||||
ROIC % | -22.01 | |||||
3-Year ROIIC % | -384.44 | |||||
ROC (Joel Greenblatt) % | -57.34 | |||||
ROCE % | -33.85 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 7.06 | |||||
PB Ratio | 1.1 | |||||
Price-to-Tangible-Book | 1.54 | |||||
EV-to-EBIT | -3.41 | |||||
EV-to-EBITDA | -3.59 | |||||
EV-to-Revenue | 9.52 | |||||
EV-to-FCF | -10.54 | |||||
Price-to-GF-Value | 1.1 | |||||
Price-to-Median-PS-Value | 1.41 | |||||
Earnings Yield (Greenblatt) % | -29.26 | |||||
FCF Yield % | -12.46 | |||||
Forward Rate of Return (Yacktman) % | -8.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vista Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 53.995 | ||
| EPS (TTM) (₹) | -1.98 | ||
| Beta | 0.6158 | ||
| 3-Year Sharpe Ratio | -0.13 | ||
| 3-Year Sortino Ratio | -0.22 | ||
| Volatility % | 40.91 | ||
| 14-Day RSI | 42.9 | ||
| 14-Day ATR (₹) | 0.535329 | ||
| 20-Day SMA (₹) | 7.047 | ||
| 12-1 Month Momentum % | -30.52 | ||
| 52-Week Range (₹) | 5.71 - 11.45 | ||
| Shares Outstanding (Mil) | 61.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vista Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vista Pharmaceuticals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vista Pharmaceuticals Ltd Frequently Asked Questions
What is Vista Pharmaceuticals Ltd(BOM:524711)'s stock price today?
The current price of BOM:524711 is ₹6.75. The 52 week high of BOM:524711 is ₹11.45 and 52 week low is ₹5.71.
When is next earnings date of Vista Pharmaceuticals Ltd(BOM:524711)?
The next earnings date of Vista Pharmaceuticals Ltd(BOM:524711) is .
Does Vista Pharmaceuticals Ltd(BOM:524711) pay dividends? If so, how much?
Vista Pharmaceuticals Ltd(BOM:524711) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Vista Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers